NCT02532712View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chemotherapy-Induced Neutropenia
Interventions
DRUG

EC-18

EC-18 Soft-capsule (500mg/1 capsule)

DRUG

Placebo

Placebo with same shape and size

Trial Locations (1)

Unknown

Yonsei University Health System, Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Enzychem Lifesciences Corporation

INDUSTRY